CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | Krishnan Krish S President and CEO | Option exercise | +8,750 | 1,486,806 | ||
| 2026-02-27 | Krishnan Krish S President and CEO | Shares withheld for taxes | −3,981 | $275.64 | $1.1M | 1,482,825 |
| 2026-02-27 | Krishnan Krish S President and CEO | Option exercise | +26,250 | 1,509,075 | ||
| 2026-02-27 | Krishnan Krish S President and CEO | Shares withheld for taxes | −11,942 | $275.64 | $3.3M | 1,497,133 |
| 2026-02-27 | Krishnan Krish S President and CEO | Option exercise | +5,725 | 1,502,858 | ||
| 2026-02-27 | Krishnan Krish S President and CEO | Shares withheld for taxes | −2,605 | $275.64 | $718K | 1,500,253 |
| 2026-02-27 | Krishnan Krish S President and CEO | Option exercise | +22,500 | 1,436,211 | ||
| 2026-02-27 | Krishnan Krish S President and CEO | Shares withheld for taxes | −10,236 | $275.64 | $2.8M | 1,425,975 |
| 2026-02-27 | Krishnan Krish S President and CEO | Option exercise | +4,000 | 1,429,975 | ||
| 2026-02-27 | Krishnan Krish S President and CEO | Shares withheld for taxes | −1,820 | $275.64 | $502K | 1,428,155 |
| 2026-02-27 | Krishnan Krish S President and CEO | Option exercise · Restricted Stock Units | −8,750 | 17,500 | ||
| 2026-02-27 | Krishnan Krish S President and CEO | Option exercise · Performance Stock Units | −26,250 | 0 | ||
| 2026-02-27 | Krishnan Krish S President and CEO | Option exercise · Restricted Stock Units | −5,725 | 17,175 | ||
| 2026-02-27 | Krishnan Krish S President and CEO | Grant or award · Stock Option (Right to Buy) | +45,249 | 45,249 | ||
| 2026-02-27 | Krishnan Krish S President and CEO | Grant or award · Restricted Stock Units | +18,140 | 18,140 | ||
| 2026-02-26 | JANNEY DANIEL Director | Sale 10b5-1 | −5,103 | $275.28 | $1.4M | 87,734 |
| 2026-02-26 | JANNEY DANIEL Director | Sale 10b5-1 | −2,638 | $276.32 | $729K | 85,096 |
| 2026-02-25 | JANNEY DANIEL Director | Sale 10b5-1 | −700 | $275.00 | $193K | 92,837 |
| 2026-02-24 | JANNEY DANIEL Director | Option exercise 10b5-1 | +37,895 | $2.46 | $93K | 37,895 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −569 | $262.91 | $150K | 37,326 |
Page 7 of 35 · 689 trades